108 related articles for article (PubMed ID: 16319980)
1. Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer.
Trafalis DT; Geromichalos GD; Koukoulitsa C; Papageorgiou A; Karamanakos P; Camoutsis C
Breast Cancer Res Treat; 2006 May; 97(1):17-31. PubMed ID: 16319980
[TBL] [Abstract][Full Text] [Related]
2. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
[TBL] [Abstract][Full Text] [Related]
3. Hybrid aza-steroid alkylators in the treatment of colon cancer.
Trafalis DT
Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
[TBL] [Abstract][Full Text] [Related]
4. A preclinical survey on the efficacy of lactandrate in the treatment of colon carcinoma.
Trafalis DT; Geromichalos GD; Bountouroglou N; Koumbi D; Kontos M; Sougias D; Dalezis P; Karamanakos P; Papageorgiou A; Camoutsis C; Athanassiou AE
J BUON; 2005; 10(2):227-34. PubMed ID: 17343334
[TBL] [Abstract][Full Text] [Related]
5. Further studies on the anti-neoplastic activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [p-[bis(2-chloroethyl)amino]-phenyl]acetate (NSC 290205).
Catsoulacos P
Cancer Lett; 1984 Mar; 22(2):199-202. PubMed ID: 6704948
[TBL] [Abstract][Full Text] [Related]
6. Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid.
Wampler GL; Catsoulacos P
Cancer Treat Rep; 1977; 61(1):37-41. PubMed ID: 861962
[TBL] [Abstract][Full Text] [Related]
7. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
8. Further studies on the antineoplastic activity of homo-aza-steroidal esters.
Pairas G; Catsoulacos P; Papageorgiou A; Boutis L
Oncology; 1986; 43(6):344-8. PubMed ID: 3808565
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of homo-aza-steroidal esters of p-N, N-bis(2-chloroethyl)aminophenoxyacetic acid.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1993; 13(4):1203-8. PubMed ID: 8352545
[TBL] [Abstract][Full Text] [Related]
10. Structure--anticancer and structure--genetic activity relationships of homo-aza-steroidal esters of N,N-bis(2-chloroethyl)aminocinnamic acid isomers.
Catsoulacos P; Camoutsis C; Papageorgiou A; Margariti E; Psaraki K; Demopoulos N
J Pharm Sci; 1993 Feb; 82(2):204-8. PubMed ID: 8445536
[TBL] [Abstract][Full Text] [Related]
11. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships.
Catsoulacos P; Camoutsis C; Papageorgiou A; Adamiak-Margariti E
Anticancer Res; 1992; 12(5):1617-20. PubMed ID: 1444229
[TBL] [Abstract][Full Text] [Related]
13. Potential antitumor agent: steroidal bilactam ester of p-N, N-bis (2-chloroethyl) aminophenylacetic acid.
Catsoulacos P; Camoutsis C; Papageorgiou A
Anticancer Res; 1995; 15(3):827-30. PubMed ID: 7645966
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of the homo-aza-steroid ester 13beta-hydroxy-13alpha-amino-13,17- seco-5alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxy acetate for the treatment of malignant melanoma.
Trafalis DT; Camoutsis C; Karamanakos P; Arvanitis A; Tegou E; Ziras N; Athanassiou AE
J BUON; 2003; 8(4):333-9. PubMed ID: 17472274
[TBL] [Abstract][Full Text] [Related]
15. New compounds: antitumor activity of 3beta-hydroxy-13alpha-amino-13,17-seco-5alpha-androstan-17-oic-13,17-lactam 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrate.
Catsoulacos P; Politis D; Boutis L; Papageorgiou A
J Pharm Sci; 1978 Sep; 67(9):1342-3. PubMed ID: 690853
[TBL] [Abstract][Full Text] [Related]
16. Antitumour effect of a- and d- lactam androgen nitrogen mustards on non-small cell lung carcinoma.
Trafalis DT; Camoutsis C; Dalezis P; Papageorgiou A; Kontos M; Karamanakos P; Giannakos G; Athanassiou AE
J BUON; 2004; 9(3):275-82. PubMed ID: 17415826
[TBL] [Abstract][Full Text] [Related]
17. The effect of an estrone D-lactam steroid ester derivative on breast cancer cells and its predicted binding interactions with the ligand binding domain of estrogen receptor-alpha.
Kontos M; Nikolopoulou M; Trafalis DT; Geromichalos GD; Koukoulitsa C; Camoutsis JC; Bastounis E; Karamanakos P
Oncol Res; 2005; 16(3):129-42. PubMed ID: 16925114
[TBL] [Abstract][Full Text] [Related]
18. Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstane-17-oic-13,17-lactam(p-(bis(2-chloroethyl)amino)-phenyl) acetate(NSC 290205) in murine solid tumors.
Catsoulacos P; Wampler GL
Oncology; 1982; 39(2):109-112. PubMed ID: 7063163
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1983; 10(2):129-32. PubMed ID: 6831626
[TBL] [Abstract][Full Text] [Related]
20. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
